ENDRA Life Sciences Inc. (NDRA) Free cash flow 2017–2025
ENDRA Life Sciences Inc. (NDRA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$5.2MFY2025 · since FY2017: -$3.3M → -$5.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.2M | +29.9% |
| FY2024 | -$7.4M | +22.6% |
| FY2023 | -$9.6M | +26.1% |
| FY2022 | -$13.0M | -16.2% |
| FY2021 | -$11.2M | -3.2% |
| FY2020 | -$10.8M | -25.4% |
| FY2019 | -$8.6M | -10.6% |
| FY2018 | -$7.8M | -135.8% |
| FY2017 | -$3.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice